| 1. |
2024
Ho KH,Hsu SY,Chen PH,Cheng CH,Liu AJ,Chien MH , Chen KC.
Hypoxia enhances IL-8 signaling through inhibiting miR-128-3p expression in glioblastomas
. Biochim Biophys Acta Mol Cell Res
.2024
|
|
| 2. |
2024
Lin YW, Wen YC,Lin CY,Hsiao CH,Ho KH,Huang HC, Chang LC, Wang SS, Yang SF, Chien MH.
Genetic variants of ADAM9 as potential predictors for biochemical recurrence in prostate cancer patients after receiving a radical prostatectomy
. Int J Med Sci
.2024
|
|
| 3. |
2024
Yang YC,Ho KH,Hua KT,Chien MH.
Roles of K(H)SRP in modulating gene transcription throughout cancer progression: Insights from cellular studies to clinical perspectives
. BBA - Reviews on Cancer
.2024
|
|
| 4. |
2024
Wen YC,Lin YW,Ho KH,Yang YC,Lai FR,Chu CY , Chen JQ, Lee WJ, Chien MH.
The oncogenic ADAMTS1-VCAN-EGFR cyclic axis drives anoikis resistance and invasion in renal cell carcinoma
. Cell Mol Biol Lett
.2024
|
|
| 5. |
2024
Chien MH,Yang YC,Ho KH ,Ding YF,Chen LH,Chiu WK, Chen JQ, Tung MC, Hsiao M, Lee WJ.
Cyclic increase in the ADAMTS1-L1CAM-EGFR axis promotes the EMT and cervical lymph node metastasis of oral squamous cell carcinoma
. Cell Death & Disease
.2024
|
|
| 6. |
2023
Ho KH,Pan KF,Cheng TY,Chien MH,Hua KT.
Multiple impacts of Naa10p on cancer progression: Molecular functions and clinical prospects
. BBA - Reviews on Cancer
.2023
|
|
| 7. |
2022
Kuo YY,Ho KH,Shih CM,Chen PH ,Liu AJ ,Chen KC.
Piperlongumine-inhibited TRIM14 signaling sensitizes glioblastoma cells to temozolomide treatment
. Life Sciences
.2022
|
|
| 8. |
2021
Ho KH,Shih CM,Liu AJ,Chen KC .
Hypoxia-inducible lncRNA MIR210HG interacting with OCT1 is involved in glioblastoma multiforme malignancy
. Cancer Science
.2021
|
|
| 9. |
2021
Lee CC,Ho KH,Huang TW,Shih CM,Hsu SY,Liu AJ, Chen KC.
A regulatory loop among CD276, miR-29c-3p, and Myc exists in cancer cells against natural killer cell cytotoxicity
. Life Sciences
.2021
|
|
| 10. |
2021
Ho KH,Lee YT,Chen PH,Shih CM,Cheng CH ,Chen KC.
Guanabenz sensitizes glioblastoma cells to sunitinib by inhibiting GADD34-mediated autophagic signaling
. Neurotherapeutics
.2021
|
|
| 11. |
2021
Ho KH,Huang TW,Liu AJ ,Shih CM,Chen KC.
Cancer Essential Genes Stratified Lung Adenocarcinoma Patients with Distinct Survival Outcomes and Identified a Subgroup from the Terminal Respiratory Unit Type with Different Proliferative Signatures in Multiple Cohorts
. Cancers
.2021
|
|
| 12. |
2021
Ho KH,Huang TW,Shih CM,Lee YT,Liu AJ,Chen PH, Chen KC.
Glycolysis-associated lncRNAs identify a subgroup of cancer patients with poor prognoses and a high-infiltration immune microenvironment
. BMC medicine
.2021
|
|
| 13. |
2020
Ho KH,Kuo TC,Lee YT,Chen PH ,Shih CM,Cheng CH, Liu AJ, Lee CC, Chen KC.
Xanthohumol regulates miR-4749-5p-inhibited RFC2 signaling in enhancing temozolomide cytotoxicity to glioblastoma
. Life Sci
.2020
|
|
| 14. |
2020
Ho KH,Chen PH,Chou CM,Shih CM,Lee YT,Cheng CH, Chen KC .
A key role of DNA damage-inducible transcript 4 (DDIT4) connects autophagy and GLUT3-mediated stemness to desensitize temozolomide efficacy in glioblastomas
. Neurotherapeutic
.2020
|
|
| 15. |
2020
Ho KH,Chen PH,Shih CM,Lee YT,Cheng CH, Liu AJ, Lee CC, Chen KC.
miR-4286 is Involved in Connections Between IGF-1 and TGF-β Signaling for the Mesenchymal Transition and Invasion by Glioblastomas
. Cell Mol Neurobiol
.2020
|
|
| 16. |
2019
Chen KC,Chen PH,Ho KH,Shih CM,Chou CM,Cheng CH, Lee CC.
IGF-1-enhanced miR-513a-5p signaling desensitizes glioma cells to temozolomide by targeting the NEDD4L-inhibited Wnt/β-catenin pathway
. PLoS One
.2019
|
|
| 17. |
2019
Ho KH,Cheng CH,Chou CM,Chen PH,Liu AJ,Lin CW, Shih CM, Chen KC.
miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme
. Pharmacol Res
.2019
|
|